Pasithea Therapeutics Corp.

US$0.58As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KTTAHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (59.81%)
Div yield —
ROE (65.49%)
Biotechnology
Beta (5Y) 0.44
PE TTM —
TSR TTM (28.87%)
Mkt cap US$19.34M
ROIC (38.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.72
24.35%
(55.72%)
Hold 0|12|11|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
9.43%
4.98%
17.47%
16.63%
Revenue$M
1.763
1.778
1.871
1.871
5.16%
7.08%
10.64%
6.98%
Peers (US$19.34M)
Cap (US$)
PE
19.32M
—
Capital
TTM
5Y
10Y
Leveragex
1.445
0.029
0.035
EBIT/Intx
1.148
2.963
1.839
Own earn%
34.67
102.89
102.53
Sh yield%
33.99
27.07
30.08
Owners
Insiders/Inst%
7.03
69.25
Short interest%
0.66
SBC / revenue%
5.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
12–15
$1 testx
0.0
Incr. ROIC%
13